(firstQuint)Targin Cancer Pain.

 This is a randomised, double-blind, double-dummy, parallel group study using OXN and OXY PR to treat moderate to severe, chronic cancer pain.

 Subjects with documented history of cancer pain that requires around the clock opioid therapy will be included.

 Subjects must have a medical history of constipation that was induced by, or worsened by their opioid therapy.

.

 Targin Cancer Pain@highlight

To Determine the Safety and Efficacy of Oxycodone / Naloxone Prolonged Release Tablets compared to Oxycodone PR in Subjects with Moderate to Severe, Chronic Cancer Pain